Intramuscular injection of plasmid DNA encoding cottontail rabbit papillomavirus E1, E2, E6 and E7 induces T cell-mediated but not humoral immune responses in rabbits

Vaccine

Volumn 17, Issue 11-12, 1999, Pages 1558-1566

  Han, Ricai ^a   Reed, Cynthia A ^a   Cladel, Nancy M ^a   Christensen, Neil D ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Antiviral immunity; DNA vaccine; Papillomavirus

Indexed keywords

DNA VACCINE; PLASMID DNA; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; DNA SEQUENCE; DRUG EFFICACY; HUMORAL IMMUNITY; IMMUNOSTIMULATION; INTRAMUSCULAR DRUG ADMINISTRATION; MONONUCLEAR CELL; NONHUMAN; ONCOVIRINAE; PAPILLOMA; PRIORITY JOURNAL; RABBIT; RESTRICTION SITE; TREATMENT OUTCOME; TUMOR REGRESSION;

ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; COTTONTAIL RABBIT PAPILLOMAVIRUS; DNA, VIRAL; INJECTIONS, INTRAMUSCULAR; LEUKOCYTES, MONONUCLEAR; PAPILLOMAVIRUS INFECTIONS; PLASMIDS; RABBITS; T-LYMPHOCYTES; TUMOR VIRUS INFECTIONS; VACCINES, DNA; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0033577253     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00356-9     Document Type: Article

References (38)

1. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol. 186:1994;131-156.
2. Hildesheim A. Human papillomavirus variants: Implications for natural history studies and vaccine development efforts. J Nat Can Ins. 89:1997;752-753.
3. Sundaram P., Tigelaar R.E., Brandsma J.L. Intracutaneous vaccination of rabbits with the cottontail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge. Vaccine. 15:1997;664-671.
4. Donnelly J.J., Martinez D., Jansen K.U., Ellis R.W., Montgomery D.L., Liu M.A. Protection against papillomavirus with a polynucleotide vaccine. J Infect Dis. 173:1996;314-320.
5. Christensen N.D., Reed C.A., Cladel N.M., Han R., Kreider J.W. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J Virol. 70:1996;960-964.
6. Breitburd F., Kirnbauer R., Hubbert N.L., Nonnenmacher B., Trin-Dinh-Desmarquet C., Orth G.et al. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol. 69:1995;3959-3963.
7. Jansen K.U., Rosolowsky M., Schultz L.D., Markus H.Z., Cook J.C., Donnelly J.J.et al. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine. 13:1995;1509-1514.
8. Suzich J.A., Ghim S.-J., Palmer-Hill F.J., White W.I., Tamura J.K., Bell J.A.et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA. 92:1995;11553-11557.
9. Chiang C.M., Ustav M., Stenlund A., Ho T.F., Broker T.R., Chow L.T. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci USA. 89:1992;5799-5803.
10. Chow L., Broker T.R. Papillomavirus DNA replication. Intervirology. 37:1994;150-158.
11. Del Vecchio A.M., Romanczuk H., Howley P.M., Baker C.C. Transient replication of human papillomavirus DNAs. J Virol. 66:1992;5949-5958.
12. Fuchs P.G., Pfister H. Transcription of papillomavirus genomes. Intervirology. 37:1994;159-167.
13. Münger K., Phelps W.C., Bubb V., Howley P.M., Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 63:1989;4417-4421.
14. Phelps W.C., Yee C.L., Münger K., Howley P.M. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell. 53:1988;539-547.
15. Germain R.N. MHC-dependent antigen processing and peptides presentation: providing ligands for lymphocyte activation. Cell. 76:1994;287-299.
16. Selvakumar R., Borenstein L.A., Lin Y.-L., Ahmed R., Wettstein F.O. Immunization with nonstructure proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas. J Viol. 69:1995;602-605.
17. Jensen E.R., Selvakumar R., Shen H., Ahmed R., Wettstein F.O., Miller J.F. Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA. J Virol. 71:1997;8467-8474.
18. Sundaram P., Tigelaar R.E., Xiao W., Brandsma J.L. Intracutaneous vaccination of rabbits with the E6 gene of cottontail rabbit papillomavirus provides partial protection against virus challenge. Vaccine. 16:1998;613-623.
19. b mice. J Immunol. 156:1996;3687-3695.
20. Fynan E.F., Robinson H.L., Webster R.G. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol. 12:1993;785-789.
21. Wang B., Boyer J., Srikantan V., Coney L., Carrano R., Phan C.et al. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol. 12:1993;799-805.
22. Lagging L.M., Meyer K., Hoft D., Houghton M., Belshe R.B., Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol. 69:1995;5859-5863.
23. Major M.E., Vitvitski L., Mink M.A., Schleef M., Whalen R.G., Trepo C.et al. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol. 69:1995;5798-5805.
24. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
25. Davis HL, Michel M-L, Whalen RG. Use of plasmid DNA for direct gene transfer and immunization. In: Liu MA, Hilleman MR, Kurth R, editors. DNA vaccines: a new era in vaccinology. New York: New York Academy of Sciences, 1995. p. 21-29.
26. Smotkin D., Wettstein F.O. The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol. 61:1987;1686-1689.
27. Barbosa M.S., Edmonds C., Fisher C., Schiller J.T., Lowy D.R., Vousden K.H. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J. 9:1990;153-160.
28. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A.et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
29. Doe B.M.S., Barnett S., Baenziger J., Walker C.M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA. 93:1996;8578-8583.
30. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med. 184:1996;1555-1560.
31. Iwasaki A., Torres C.A.T., Ohashi P.S., Robinson H.L., Barber B.H. The dominant role of bone marrow-derived cells in CTL induction following plasid DNA immunization at different sites. J Immunol. 159:1997;11-14.
32. Kovacsovics-Bankowski M., Rock K.L. A phagosome to cytosol pathway for exogenous antigens presented by MHC class I molecules. Science. 267:1995;243-246.
33. Falo L.D.J., Kovacsovics-Bankowski M., Thompson K., Rock K.L. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nature Med. 1:1995;649-653.
34. Suto R., Srivastava P.K. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science. 269:1995;1585-1588.
35. Chattergoon M.A., Robinson T.M., Boyer J.D., Weiner D.B. Specific immune induction following DNA-based immunination through in vivo transfection and activation of macrophages/antigen-presenting cells. J Immunol. 160:1998;5707-5718.
36. Torres C.A.T., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunization. J Immunol. 158:1997;4529-4532.
37. Han R., Breitburd F., Marche P.N., Orth G. Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes. Nature. 356:1992;66-68.
38. Lin Y.L., Borenstein L.A., Selvakumar R., Ahmed R., Wettstein F.O. Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteins. J Virol. 67:1993;382-389.